Grocery Outlet Enlists iFoodDS for FSMA 204 Traceability Compliance — Neutral
GO PRNewsWire — May 07, 2025EMERYVILLE, Calif. and SEATTLE , May 7, 2025 /PRNewswire/ -- iFoodDS, a leading provider of food traceability software, today announced Grocery Outlet (NASDAQ: GO), a leading extreme-value grocery retailer, will implement its traceability software for FSMA 204 compliance.

Disney Beats Estimates, Boosts Profit Forecast on Parks, Streaming — Positive
DIS Bloomberg Markets and Finance — May 07, 2025Disney saw fiscal second-quarter results that beat Wall Street estimates and raised its outlook for the full year as it benefited from faster-than-expected growth at its namesake parks and streaming business. Geetha Ranganathan of Bloomberg Intelligence has more.

Rivian Q1 Earnings Surpass Expectations, Revenues Rise Y/Y — Positive
RIVN Zacks Investment Research — May 07, 2025RIVN reports better-than-expected Q1 results and expects to deliver 40,000 to 46,000 vehicles in 2025, down from the previous estimate of 46,000-51,000 units.

Taboola.com Ltd. (TBLA) Tops Q1 Earnings and Revenue Estimates — Positive
TBLA Zacks Investment Research — May 07, 2025Taboola.com Ltd. (TBLA) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.01 per share.

Fortis (FTS) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.69 per share a year ago.

Levi & Korsinsky Notifies Shareholders of BigBear.ai Holdings, Inc. (BBAI) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
BBAI Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=147282&wire=1 or contact Joseph E. Levi, Esq.

May 20, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against PPTA — Neutral
PPTA Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=147285&wire=1 or contact Joseph E. Levi, Esq.

EU LAWSUIT ALERT: Levi & Korsinsky Notifies enCore Energy Corp. Investors of a Class Action Lawsuit and Upcoming Deadline — Neutral
EU Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=147283&wire=1 or contact Joseph E. Levi, Esq.

Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA — Neutral
SANA Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=147284&wire=1 or contact Joseph E. Levi, Esq.

Booking Holdings posted strong Q1 results, increasing revenue and bookings despite economic uncertainties, showcasing its resilience and long-term potential. The company has a history of share buybacks and recently initiated a dividend, enhancing shareholder value through increased earnings per share and growing dividends. Despite a slightly premium valuation, BKNG's consistent outperformance and strategic use of AI position it well for future growth.

Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) — Positive
HIMS Seeking Alpha — May 07, 2025Hims & Hers Health reported strong Q1 '25 earnings, with 111% YoY sales growth and 38% subscriber growth. The company boasts over a 70% gross margin, 90% recurring revenue, and a compelling flywheel effect driven by machine learning and big data analytics. Risks include the untested business model, potential legal issues, and the complexity of international expansion, but the growth potential presented far outweighs these concerns.

Rockwell Automation boosts annual profit forecast, shares jump — Positive
ROK Reuters — May 07, 2025Rockwell Automation raised its annual profit forecast on Wednesday after cost cuts helped boost margins in the second quarter, sending its shares up nearly 8% in premarket trade.

HG Vora Commences Lawsuit Against PENN Entertainment to Preserve the Fundamental Right of Shareholders to Elect All Three of Its Highly Qualified Independent Directors — Neutral
PENN Business Wire — May 07, 2025NEW YORK--(BUSINESS WIRE)--HG Vora Capital Management, LLC (together with its affiliates, “HG Vora”) today filed a complaint in the United States District Court for the Eastern District of Pennsylvania (the “Court”) against PENN Entertainment, Inc. (Nasdaq: PENN) (“PENN” or the “Company”) and its Board of Directors (the “Board”). The complaint alleges that PENN violated Pennsylvania's Business Corporation Law and the Board breached its fiduciary duties when it reduced the number of seats up for.

Dude, you're getting a Dell just doesn't have the same ring to it that it used to.

Qualys Stock Gains 4% as Q1 Earnings and Revenues Crush Estimates — Positive
QLYS Zacks Investment Research — May 07, 2025While robust channel sales drive QLYS' Q1 top-line performance, lowered expenses boost its earnings.

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Humana Inc. (HUM) — Neutral
HUM Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Humana Inc. ("Humana Inc.") (NYSE:HUM) concerning possible violations of federal securities laws. On May 1, 2025, the U.S. Department of Justice announced it had filed a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana.

PTC Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by PTC Therapeutics, Inc. (PTCT) — Neutral
PTCT Accesswire — May 07, 2025NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning possible violations of federal securities laws. PTC issued a press release on May 5, 2025, "announc[ing] results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients.

How To Earn $500 A Month From ConocoPhillips Stock Ahead Of Q1 Earnings — Positive
COP Benzinga — May 07, 2025ConocoPhillips COP will release earnings results for the first quarter, before the opening bell on Thursday, May 8.

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement — Neutral
BMRA GlobeNewsWire — May 07, 2025- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company dedicated to the development of advanced diagnostic products, announced that the Company and its CLIA laboratory partner have submitted an application to the American Medical Association (AMA) CPT Editorial Panel requesting the assignment of a Proprietary Laboratory Analysis (PLA) code for the inFoods® IBS diagnostic test.

Bio-Techne exceeds profit expectations, announces new share buyback plan — Positive
TECH Reuters — May 07, 2025Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other products for research and said it is launching a new share buyback program.
